title: Correlation between Banff classification and reversal of acute renal rejection.
authors.affiliation: Department of Urology, Osaka University Medical School, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kokado
authors.forename: M
authors.initials: M
authors.lastname: Kyo
authors.forename: S
authors.initials: S
authors.lastname: Takahara
authors.forename: N
authors.initials: N
authors.lastname: Ichimaru
authors.forename: J D
authors.initials: JD
authors.lastname: Wang
authors.forename: K
authors.initials: K
authors.lastname: Toki
authors.forename: T
authors.initials: T
authors.lastname: Miki
authors.forename: A
authors.initials: A
authors.lastname: Okuyama
mesh_terms: D000208:Acute Disease; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D006084:Graft Rejection / Q000145:classification* / Q000188:drug therapy / Q000473:pathology; D006085:Graft Survival; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D006146:Guanidines; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; C037258:gusperimus; D008775:Methylprednisolone